SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-18-002942
Filing Date
2018-03-08
Accepted
2018-03-08 16:52:22
Documents
74
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K mrtx-20171231x10k.htm 10-K 1473963
2 EXHIBIT 21.1 exhibit211.htm EX-21.1 3770
3 EXHIBIT 23.1 mrtx-20171231xex231.htm EX-23.1 7747
4 EXHIBIT 31.1 mrtx-20171231xex311.htm EX-31.1 12436
5 EXHIBIT 31.2 mrtx-20171231xex312.htm EX-31.2 13494
6 EXHIBIT 32.1 mrtx-20171231xex321.htm EX-32.1 8093
13 capture.jpg GRAPHIC 78518
14 GRAPHIC miratipipelinea01.jpg GRAPHIC 100017
  Complete submission text file 0001628280-18-002942.txt   6547731

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT mrtx-20171231.xml EX-101.INS 1365996
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrtx-20171231.xsd EX-101.SCH 42599
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mrtx-20171231_cal.xml EX-101.CAL 64060
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mrtx-20171231_def.xml EX-101.DEF 165539
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrtx-20171231_lab.xml EX-101.LAB 557222
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrtx-20171231_pre.xml EX-101.PRE 307123
Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35921 | Film No.: 18677158
SIC: 2834 Pharmaceutical Preparations